For instance, studies in ovarian cancer had shown that ADM promoted platinum-based chemotherapy resistance by upregulating glycolysis via PKM2, consistent with our observation of ADM’s negative correlation with certain chemotherapeutic agents (35, 52). This evidence concerns the gene PKM and ovarian carcinoma.